ES8603862A1 - Procedimiento para la obtencion de derivados de indol - Google Patents

Procedimiento para la obtencion de derivados de indol

Info

Publication number
ES8603862A1
ES8603862A1 ES537917A ES537917A ES8603862A1 ES 8603862 A1 ES8603862 A1 ES 8603862A1 ES 537917 A ES537917 A ES 537917A ES 537917 A ES537917 A ES 537917A ES 8603862 A1 ES8603862 A1 ES 8603862A1
Authority
ES
Spain
Prior art keywords
alkyl
radical
group
indole derivatives
monosubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537917A
Other languages
English (en)
Other versions
ES537917A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES537917A0 publication Critical patent/ES537917A0/es
Publication of ES8603862A1 publication Critical patent/ES8603862A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE INDOL. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN PRESENCIA DE UNA BASE ORGANICA, EN UN DISOLVENTE, TALES COMO, HIDROCARBUROS, CETONAS, ALCOHOLES, ETERES, AMIDAS, NITRILOS, A UNA TEMPERATURA ENTRE 20JC Y 130JC, DURANTE ALGUNOS MINUTOS HASTA 14 DIAS, PARA OBTENER UN COMPUESTO DE FORMULA (I). SIENDO: A, -(CH2)N, CH2-S-CH2CH2-, CH2-SO-CH2CH2- O -CH2-SO2-CH2CH2; IND, RESTO DE INDOL-3-ILO SUSTITUIDO POR UN GRUPO HIDROXIMETILO O COW; N,2,3,4 O 5; W,H,OH, O ALQUILO, NH2, NH ALQUILO O N(ALQUILO)2; X1, X O NH2; C, CL, BR, J, OH O GRUPO OH FUNCIONALMENTE MODIFICADO; X2 Y X3, IGUALES O DIFERENTES, X, NH; LOS DOS RESTOS Y, H O C-C; Y DOS RESTOS Z, UNO AR Y EL OTRO H. SE UTILIZA PARA LA OBTENCION DE PREPARADOS FARMACEUTICOS.
ES537917A 1983-11-25 1984-11-23 Procedimiento para la obtencion de derivados de indol Expired ES8603862A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833342632 DE3342632A1 (de) 1983-11-25 1983-11-25 Indolderivate

Publications (2)

Publication Number Publication Date
ES537917A0 ES537917A0 (es) 1986-01-01
ES8603862A1 true ES8603862A1 (es) 1986-01-01

Family

ID=6215232

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537917A Expired ES8603862A1 (es) 1983-11-25 1984-11-23 Procedimiento para la obtencion de derivados de indol

Country Status (12)

Country Link
EP (1) EP0144012B1 (es)
JP (1) JPS60132980A (es)
AT (1) ATE33026T1 (es)
AU (1) AU570281B2 (es)
CA (1) CA1257597A (es)
DE (2) DE3342632A1 (es)
ES (1) ES8603862A1 (es)
HK (1) HK93190A (es)
IE (1) IE57641B1 (es)
MX (1) MX9203612A (es)
SG (1) SG77490G (es)
ZA (1) ZA849181B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
EP0187122A3 (de) * 1985-01-03 1987-12-16 Ciba-Geigy Ag 1,3,4-Trisubstituierte Azacycloalkane bzw. Azacycloalkene
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
DE3604949A1 (de) * 1986-02-17 1987-08-20 Merck Patent Gmbh Hydroxyindolester
DE3907974A1 (de) * 1989-03-11 1990-09-13 Merck Patent Gmbh Indolderivate
DE4101686A1 (de) 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
DE4141268A1 (de) * 1991-12-14 1993-06-17 Merck Patent Gmbh Pharmazeutische zubereitung
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
PE20060373A1 (es) 2004-06-24 2006-04-29 Smithkline Beecham Corp Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
JP2012520257A (ja) 2009-03-10 2012-09-06 グラクソ グループ リミテッド Ikk2阻害剤としてのインドール誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183235A (en) * 1961-06-27 1965-05-11 Sterling Drug Inc 1-[3-, 2-, and 1-indolyl-lower-alkanoyl] piperidines
SE307788B (es) * 1965-04-23 1969-01-20 Yoshitomi Pharmaceutical
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
FR1545887A (fr) * 1967-10-05 1968-11-15 Centre Nat Rech Scient Dérivés de l'indole et leur préparation
EP0007399B1 (de) * 1978-06-24 1982-01-20 MERCK PATENT GmbH Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE2827874A1 (de) * 1978-06-24 1980-02-07 Merck Patent Gmbh Indolalkylamine und verfahren zu ihrer herstellung
US4464379A (en) * 1981-06-01 1984-08-07 A. Nattermann & Cie Gmbh Indol acetic acid derivatives and anti-inflamatory and related uses thereof
ZA826760B (en) * 1981-09-17 1983-07-27 Beecham Group Plc Active compounds
DE3236243A1 (de) * 1982-09-30 1984-04-05 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige indolderivate
DE3301758A1 (de) * 1983-01-20 1984-07-26 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
DE3308668A1 (de) * 1983-03-11 1984-09-13 Merck Patent Gmbh, 6100 Darmstadt Indolderivate

Also Published As

Publication number Publication date
AU3566084A (en) 1985-05-30
EP0144012A1 (de) 1985-06-12
IE843010L (en) 1986-05-25
ATE33026T1 (de) 1988-04-15
SG77490G (en) 1990-11-23
EP0144012B1 (de) 1988-03-16
MX9203612A (es) 1992-09-30
AU570281B2 (en) 1988-03-10
IE57641B1 (en) 1993-02-10
DE3469900D1 (de) 1988-04-21
ZA849181B (en) 1985-07-31
CA1257597A (en) 1989-07-18
ES537917A0 (es) 1986-01-01
DE3342632A1 (de) 1985-06-05
HK93190A (en) 1990-11-16
JPS60132980A (ja) 1985-07-16
JPH047745B2 (es) 1992-02-12

Similar Documents

Publication Publication Date Title
ES8603862A1 (es) Procedimiento para la obtencion de derivados de indol
EP0363198A3 (en) Positive working photosensitive composition
KR830001869A (ko) 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
GR72243B (es)
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
BG41822A3 (en) Method for preparing pyridyl derivatives
SG94086G (en) Sulphur-containing indole derivatives
ES8502108A1 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
GB1229082A (es)
ES8703424A1 (es) Procedimiento para la obtencion de compuestos de amida
ES8504761A1 (es) Un metodo para preparar derivados de 3-metilflavona
EP0166183A3 (en) Use of hydroxyindole derivatives for lowering the blood pressure
BG34334A3 (en) Method for obtaining phosphonic acid derivates
DE3471935D1 (de) Indole derivatives
BG34904A3 (en) Method for preparing d- sesquisodium salt of oxa- beta- lactam
ES8507513A1 (es) Un procedimiento para preparar derivados bis-dioxopiperazinicos
HUT38335A (en) Process for producing indol derivatives and pharmaceutical compositions containing them
JPS5283773A (en) Novel indene derivative
EP0304842A3 (en) Isoprenoid derivatives and anti-ulcer agents containing the same
GB1531611A (en) (indolin-1-yl)-guanidines
ES408595A3 (es) Un metodo para la preparacion de nuevas bencimidazolinonas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001